mortality/aging
N |
• no differences in survival are seen at 111 days, indicating no disease-related mortality
|
growth/size/body
• mice show retarded growth during the first 4 months of life
• treatment with an adeno-associated viral gene therapy expressing human MMUT (AAV-MMUT) increases body weight by an average of 45% within one week of treatment to a size not significantly different from heterozygotes
|
homeostasis/metabolism
• plasma methylmalonic acid concentrations are elevated
• gene therapy treatment with AAV-MMUT decreases plasma methylmalonic acid concentrations by over 75% 3 weeks after treatment
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | DOID:0060740 |
OMIM:251000 |
J:332892 |